biopharma-2016_scientifictracks-workshop

10 / 15

Volume 8, Issue 6 (Suppl) J Bioequiv Availab
ISSN: 0975-0851 JBB, an open access journal
Page 41
Notes:
Biopharma 2016
September 14-16, 2016
conferenceseries.com
September 14-16, 2016 San Antonio, USA
2nd International Conference & Expo on
Biopharmaceutics and Biologic Drugs
New and old technologies for the cosmetic innovation learning from the pharmaceutical world and
balancing through the regulatory requirements
Lorella Ragni
Angelini S.p.A, Italy
In the cosmetic field consumers are expecting the latest technology advances to be incorporated into innovative formulations, both
in terms of active ingredients (entering the perimeter of cosmeceutics) and in terms of delivery technologies. The recent regulatory
framework growing araound the cosmetic world, both in the EMA and FDA perimeters, is somewhat changing the way of pursuing
innovation in this field. Cosmetics formulators today are looking more and more to mutuate technologies from the pharmaceutical
world, looking both at the delivery sisthems and at the new functional ingredients. This cross-contamination between pharmaceutical
and cosmeceutical technologies is very important to promote innovation in this field, and can also maximize the return of the
research investment for companies that have a pipeline involving both types of products. However, the challenge is not only to respect
regulatory requirements that are constantly evolving in the cosmetic and cosmeceutics world, but also to offer new, smart systems that
are able to deliver the active ingredients to one or more skin layers minimizing the systemic adsorption.
Biography
Lorella Ragni graduated in Chemistry and Pharmaceutical Science at Bologna University Italy. Soon after the degree she attended the Master in Cosmetic Product
Development at Ferrara University Italy. After a short experience in 1988 as researcher in Synthetic Chemistry at Ancona University Italy, since 1989 she has been
working in Angelini covering different positions in the Development Product Department. From 2001 to present she took over the position of Head of Formulation
Department. During her working experience she has been the leader of several scientific groups of formulators and analysts for the development of solid, liquid,
semisolid pharmaceutical products and new drug delivery systems. In the last five years she extended her range of activity in the formulation development of Food
Supplements, Cosmetics and Medical Device for European Market. She constantly supports the Company in the research and evaluation of new technologies for
the feeding of project pipeline and she was the author of several European and Worldwide Patents.
Lorella Ragni, J Bioequiv Availab 2016, 8:6 (Suppl)